A study on Vengara chunnam for urolithiasis patients

Single centric non-randomized open clinical trial phase II in Vatha kalladaippu (Urolithiasis) with siddha medicine Vengara chunnam among patients attending OPD at Government Siddha Medical college Hospital,Chennai. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069490

Enrollment

Registered

2024-06-26

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: Vengara Chunnam: The medicine will be given 200mgs twice a day with Adjuvant Neermulli Kudineer after food for 48 days. Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.All gender 2.Age 18-60 years 3.Lower Abdominal pain 4.Flank pain 5.Burning Micturition 6.Oliguria 7.Haematuria 8.Presence of calculi of size 4-9mm.

Exclusion criteria

Exclusion criteria: 1.Stag horn calculus 2.Hydronephrosis 3.Cancer 4.Chronic kidney disease 5.Pregnancy 6.Lactating women

Design outcomes

Primary

Measure	Time frame
Reduction in clinical symptoms such as lower abdominal pain,oliguria,dysuria.Timepoint: 90 days	—

Secondary

Measure	Time frame
Reduction in size of the stoneTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr R MENAKA

Government Siddha Medical College, Arumbakkam, Chennai

rangasamymenaka75@gmail.com9444669661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026